Joint Formulary & PAD

GP

Guideline Profile : Asthma

Drugs

Below are listed all drugs that are used to treat Asthma.

Committee Recommendations (2)

The APC approved the new asthma pathways for:

  • Adults and Over 12 years
  • Children and young people (5-11 years)

The use of High Dose Inhaled Corticosteroid (ICS) Safety Cards are recommended for use as appropriate.

Spacer devices are recommended for use with Metered Dose Inhalation (MDI) devices.

Branded prescribing of corticosteroid inhalers is recommended following the increase in the range of inhaler devices now available. Patients should be prescribed an inhaler that meets their individual needs - where there is more than one option available, the brand with the lowest acquisition cost is recommended.

Patient education videos and instruction leaflets on the correct use of their inhaler devices can be found on the PAD page for all formulary devices.

Duplicate prescribing of inhalers that contain the same medicine is a commonly reported medicines safety incident when a patient’s inhalers are changed.  The “Know your inhalers” diagram shows practice staff the class of medicine in commonly prescribed inhalers and will help to identify if there is potential for a duplicate inhaler prescribing error.

Guideline Profile

Indication :
Asthma
Keywords :
respiratory, inhalers, LAMAs, SABAs, ICS, High dose inhaled corticosteroid safety card, steroid card, inhaled steroid safety card, high dose ICS card, asthmatics, BTS
Brand Names Include :
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Supporting Documents :
11